Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 200
Filter
1.
J Investig Med High Impact Case Rep ; 11: 23247096231181060, 2023.
Article in English | MEDLINE | ID: mdl-37334970

ABSTRACT

Disseminated coccidioidomycosis is associated with significant morbidity and mortality. Involvement of the meninges is often fatal if untreated, typically requiring lifelong antifungal therapy and neurosurgical intervention. We present the case of a young male without any known immunocompromising conditions who opted exclusively for medical management of newly diagnosed coccidioidomycosis meningitis with communicating hydrocephalus and discuss the controversy associated with this approach. This case highlights the importance of shared decision-making between patient and clinician, even if the plan diverges from available guidelines. Furthermore, we discuss clinical considerations in approaching the close outpatient monitoring of patients with central nervous system coccidioidomycosis with hydrocephalus.


Subject(s)
Coccidioidomycosis , Hydrocephalus , Meningitis, Fungal , Humans , Male , Coccidioidomycosis/complications , Coccidioidomycosis/diagnosis , Coccidioidomycosis/drug therapy , Hydrocephalus/etiology , Central Nervous System/surgery , Meningitis, Fungal/diagnosis , Meningitis, Fungal/drug therapy , Ventriculoperitoneal Shunt
2.
Childs Nerv Syst ; 38(10): 1849-1854, 2022 10.
Article in English | MEDLINE | ID: mdl-35907004

ABSTRACT

INTRODUCTION: Myelomeningocele (MMC) is the most frequent neural tube defect and is frequently associated (around 80% of cases) with hydrocephalus (HC). Both diseases can have severe clinical consequences, insomuch as they require surgical treatment whose complications are not negligible, either when performed in utero or after birth. Therefore, clinical therapies that could have an impact on the incidence and progression of MMC and HC would be certainly valuable; however, this is not the current picture, and there are no effective pharmacological treatments for such patients to this day. AIM AND METHODS: Therefore, knowing that an inflammatory process comes associated with these disorders, mostly due to nervous tissue distension, the present article aimed at reviewing the role of corticosteroids in reducing inflammation and thus improving the outcome of patients with HC and MMC, considering the well-established anti-inflammatory effects of CS. RESULTS: The systematic review performed herein has found varying results regarding the role of steroids (even though a positive trend was observed) on the treatment and prevention of hydrocephalus, whereas for MMC. CONCLUSION: There are many reports demonstrating beneficial effects of CS therapy, from a clinical and histopathological point of view.


Subject(s)
Hydrocephalus , Meningomyelocele , Adrenal Cortex Hormones/therapeutic use , Anti-Inflammatory Agents , Central Nervous System/surgery , Humans , Hydrocephalus/complications , Hydrocephalus/etiology , Meningomyelocele/complications , Meningomyelocele/drug therapy , Meningomyelocele/surgery , Retrospective Studies , Ventriculoperitoneal Shunt/adverse effects
4.
STAR Protoc ; 2(3): 100666, 2021 09 17.
Article in English | MEDLINE | ID: mdl-34286294

ABSTRACT

Microglia are important immune cells in the central nervous system (CNS). Mutations in microglia may cause CNS disorders. Replacement of dysfunctional microglia with allogeneic wild-type microglia can correct the gene deficiency, thus treating the neurogenic diseases. However, traditional approaches cannot efficiently replace microglia at the adulthood. Here, we introduce a potentially clinical-feasible strategy named microglia replacement by bone marrow transplantation that achieves efficient microglia replacement at the whole CNS scale, including the brain, spinal cord, and retina in adult mice. For complete details on the use and execution of this protocol, please refer to Xu et al. (2020). The original abbreviation of this microglia replacement strategy is mrBMT. We hereby change the name to Mr BMT.


Subject(s)
Bone Marrow Cells/cytology , Bone Marrow Transplantation/methods , Central Nervous System , Microglia , Animals , Brain/cytology , Central Nervous System/cytology , Central Nervous System/surgery , Female , Male , Mice , Microglia/cytology , Microglia/physiology , Spinal Cord/cytology , Transplantation, Homologous
5.
Cell Rep ; 32(6): 108041, 2020 08 11.
Article in English | MEDLINE | ID: mdl-32783928

ABSTRACT

Microglia are important immune cells in the central nervous system (CNS). Dysfunctions of gene-deficient microglia contribute to the development and progression of multiple CNS diseases. Microglia replacement by nonself cells has been proposed to treat microglia-associated disorders. However, some attempts have failed due to low replacement efficiency, such as with the traditional bone marrow transplantation approach. In this study, we develop three efficient strategies for microglia replacement: microglia replacement by bone marrow transplantation (mrBMT), microglia replacement by peripheral blood (mrPB), and microglia replacement by microglia transplantation (mrMT). mrBMT and mrPB allow microglia-like cells to efficiently replace resident microglia in the whole CNS. On the other hand, mrMT achieves microglia replacement in brain regions of interest. In summary, the present study offers effective tactics for microglia replacement with diverse application scenarios, which potentially opens up a window on treating microglia-associated CNS disorders.


Subject(s)
Central Nervous System/physiopathology , Microglia/transplantation , Animals , Central Nervous System/surgery , Humans , Mice
6.
Nat Commun ; 11(1): 4195, 2020 08 21.
Article in English | MEDLINE | ID: mdl-32826916

ABSTRACT

Realizing a clinical-grade electronic medicine for peripheral nerve disorders is challenging owing to the lack of rational material design that mimics the dynamic mechanical nature of peripheral nerves. Electronic medicine should be soft and stretchable, to feasibly allow autonomous mechanical nerve adaptation. Herein, we report a new type of neural interface platform, an adaptive self-healing electronic epineurium (A-SEE), which can form compressive stress-free and strain-insensitive electronics-nerve interfaces and enable facile biofluid-resistant self-locking owing to dynamic stress relaxation and water-proof self-bonding properties of intrinsically stretchable and self-healable insulating/conducting materials, respectively. Specifically, the A-SEE does not need to be sutured or glued when implanted, thereby significantly reducing complexity and the operation time of microneurosurgery. In addition, the autonomous mechanical adaptability of the A-SEE to peripheral nerves can significantly reduce the mechanical mismatch at electronics-nerve interfaces, which minimizes nerve compression-induced immune responses and device failure. Though a small amount of Ag leaked from the A-SEE is observed in vivo (17.03 ppm after 32 weeks of implantation), we successfully achieved a bidirectional neural signal recording and stimulation in a rat sciatic nerve model for 14 weeks. In view of our materials strategy and in vivo feasibility, the mechanically adaptive self-healing neural interface would be considered a new implantable platform for a wide range application of electronic medicine for neurological disorders in the human nervous system.


Subject(s)
Electronics, Medical/instrumentation , Electronics, Medical/methods , Neurosurgery/instrumentation , Neurosurgery/methods , Peripheral Nerves/physiology , Animals , Biomedical Engineering/instrumentation , Biomedical Engineering/methods , Central Nervous System/physiology , Central Nervous System/surgery , Gold , Humans , Male , Materials Testing , Models, Animal , Nerve Tissue/pathology , Nerve Tissue/surgery , Peripheral Nerves/pathology , Peripheral Nerves/surgery , Polymers/chemistry , Prostheses and Implants , Rats , Sciatic Nerve , Wearable Electronic Devices
7.
Biomed Res Int ; 2020: 2536272, 2020.
Article in English | MEDLINE | ID: mdl-32461970

ABSTRACT

METHODS: circRNA expression was analysed in six cerebrospinal fluid (CSF) samples from three patients of the infectious and noninfectious phases using an Arraystar Human circRNA Array. Differentially altered circRNAs were validated by quantitative real-time polymerase chain reaction (qRT-PCR) in the 66 CSF samples of 33 patients of the infectious and noninfectious phases. t-test was used for statistical analysis. A bioinformatics analysis was employed to investigate the function mechanism of the circRNAs. RESULTS: Firstly, 142 circRNAs were found significantly different in 6 CSF samples of the infection and noninfection phases of 3 patients. Fourteen circRNAs with the top largest fold changes were chosen from the 142 circRNAs for PCR validation in the same 6 CSF samples of 3 patients. Three circRNAs were selected to be validated in 60 CSF samples of 30 patients using the PCR test. In infection CSF, an upregulated hsa_circRNA_402632 and downregulated hsa_circRNA_008636 and hsa_circRNA_405481 were confirmed by PCR test. A bioinformatics analysis was used to investigate the function mechanism of the 3 circRNAs. hsa_circRNA_402632 is enriched in the insulin resistance pathway, the FoxO and AMPK signaling pathways are the most important pathways for hsa_circRNA_008636 gene expression, and hsa_circRNA_405481 is enriched in the endometrial cancer signaling pathway, Fc epsilon RI signaling pathway, and TGF-beta signaling pathway. CONCLUSIONS: hsa_circRNA_402632, hsa_circRNA_008636, and hsa_circRNA_405481 may be potential diagnostic markers for central nervous system infection after neurological surgery.


Subject(s)
Central Nervous System/metabolism , Gene Expression Regulation , Infections , RNA, Circular/genetics , RNA, Circular/metabolism , Adult , Aged , Aged, 80 and over , Biomarkers , Central Nervous System/surgery , Computational Biology , Female , Humans , Male , Middle Aged , RNA, Circular/cerebrospinal fluid , Real-Time Polymerase Chain Reaction , Signal Transduction/genetics
8.
World Neurosurg ; 134: 635-640.e1, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31704362

ABSTRACT

BACKGROUND: Calcifying pseudoneoplasm of the neuraxis (CAPNON) is a rare clinical entity. We report an unusual case of intraparenchymal bifrontal CAPNON coexisting with interhemispheric lipoma and agenesis of the corpus callosum. CASE DESCRIPTION: A 64-year-old woman presented with slight weakness of her left leg. Computed tomography and magnetic resonance imaging showed massive nodular intraparenchymal calcifications at both sides of the interhemispheric lipoma associated with partial agenesis of the corpus callosum. Enhancement was observed at the periphery and within the calcification. Massive perifocal edema was also demonstrated. The enhanced lesion with calcification was partially resected. Histologic analysis of the resected specimen disclosed nodular calcification with fibro-osseous components and histiocytic reaction, consistent with CAPNON. A high ratio of M2 macrophages was observed among the infiltrating macrophages. 11C-methionine positron emission tomography demonstrated high uptake of the tracer at the lesion corresponding to the calcified lesion on computed tomography. Postoperatively, massive perifocal edema was decreased and maintained without progression for a year. CONCLUSIONS: The high M2 macrophage activity verified by histopathologic analysis suggests that CAPNON is not a silent but a more active, tumefactive disease involving the immune response. This hypothesis may be supported by the high uptake of 11C-methionine positron emission tomography.


Subject(s)
Brain Diseases/surgery , Corpus Callosum/surgery , Lipoma/surgery , Macrophages/pathology , Brain Diseases/diagnosis , Brain Neoplasms/diagnosis , Brain Neoplasms/pathology , Brain Neoplasms/surgery , Central Nervous System/surgery , Corpus Callosum/pathology , Humans , Lipoma/complications , Lipoma/diagnosis , Male , Middle Aged , Treatment Outcome
9.
PLoS One ; 14(10): e0222721, 2019.
Article in English | MEDLINE | ID: mdl-31574089

ABSTRACT

BACKGROUND: Delirium is the most common postoperative complication of the central nervous system (CNS) that can trigger long-term cognitive impairment. Its underlying mechanism is not fully understood, but the dysfunction of the blood-brain barrier (BBB) has been implicated. The serum levels of the axonal damage biomarker, phosphorylated neurofilament heavy subunit (pNF-H) increase in moderate to severe delirium patients, indicating that postoperative delirium can induce irreversible CNS damage. Here, we investigated the relationship among postoperative delirium, CNS damage and BBB dysfunction, using pNF-H as reference. METHODS: Blood samples were collected from 117 patients within 3 postoperative days. These patients were clinically diagnosed with postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit. We measured intercellular adhesion molecule-1, platelet and endothelial cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and P-selectin as biomarkers for BBB disruption, pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6), and pNF-H. We conducted logistic regression analysis including all participants to identify independent biomarkers contributing to serum pNF-H detection. Next, by multiple regression analysis with a stepwise method we sought to determine which biomarkers influence serum pNF-H levels, in pNF-H positive patients. RESULTS: Of the 117 subjects, 41 were clinically diagnosed with postoperative delirium, and 30 were positive for serum pNF-H. Sensitivity and specificity of serum pNF-H detection in the patients with postoperative delirium were 56% and 90%, respectively. P-selectin was the only independent variable to associate with pNF-H detection (P < 0.0001) in all 117 patients. In pNF-H positive patients, only PECAM-1 was associated with serum pNF-H levels (P = 0.02). CONCLUSIONS: Serum pNF-H could be an objective delirium biomarker, superior to conventional tools in clinical settings. In reference to pNF-H, P-selectin may be involved in the development of delirium-related CNS damage and PECAM-1 may contribute to the progression of delirium- related CNS damage.


Subject(s)
Biomarkers/blood , Central Nervous System/physiopathology , Delirium/blood , Neurofilament Proteins/blood , Postoperative Complications/blood , Aged , Axons/metabolism , Axons/pathology , Blood-Brain Barrier/metabolism , Blood-Brain Barrier/physiopathology , Central Nervous System/metabolism , Central Nervous System/surgery , Delirium/etiology , Delirium/physiopathology , Disease Progression , E-Selectin/blood , Female , Humans , Intercellular Adhesion Molecule-1/blood , Male , Middle Aged , P-Selectin/blood , Platelet Endothelial Cell Adhesion Molecule-1/blood , Postoperative Complications/pathology , Vascular Cell Adhesion Molecule-1/blood
10.
Methods Mol Biol ; 2036: 237-248, 2019.
Article in English | MEDLINE | ID: mdl-31410801

ABSTRACT

The present protocol describes in detail the steps necessary for executing two highly versatile and minimally invasive surgical approaches for localized delivery of compounds to the central nervous system. The procedures have been designed for use on laboratory mice but can also be tailored for experimentations involving other small rodent models. Following the instructions outlined below, treatments can either be administered through single injections or infused over a longer period of time, at locations identified through stereotaxic coordinates, which ensure efficient targeting of the brain region of interest, as well as increased reproducibility between surgeries. Although the surgical interventions are well tolerated by laboratory animals, it is recommended to closely monitor the mice postoperatively for a few days, and take the necessary measures to prevent stress and discomfort.


Subject(s)
Central Nervous System Agents/administration & dosage , Central Nervous System/drug effects , Animals , Central Nervous System/metabolism , Central Nervous System/surgery , Drug Administration Routes , Infusion Pumps , Injections/methods , Mice , Microinjections/methods , Minimally Invasive Surgical Procedures , Postoperative Care
11.
Zhonghua Wai Ke Za Zhi ; 57(8): 607-615, 2019 Aug 01.
Article in Chinese | MEDLINE | ID: mdl-31422631

ABSTRACT

Objective: To evaluate the effect of hybrid operation suite in the treatment of cerebral and spinal vascular diseases and intracranial hypervascular tumors. Methods: A retrospective study was conducted on 132 patients with various cerebral and spinal vascular diseases and intracranial hypervascular tumors who were treated by hybrid surgery at Department of Neurosurgery, Huashan Hospital from October 2016 to December 2017.There were 70 male and 62 female patients with a mean age of 48.33 years (range: 14-78 years), including 64 cases of intracranial aneurysm (41 complicated aneurysm cases), 28 cases of brain arteriovenous malformation (BAVM), 12 cases of hypervascular tumor, 12 cases of dural arteriovenous fistula (DAVF), 6 cases of carotid artery stenosis, 5 cases of Moyamoya disease, 3 cases of intracranial aneurysm or BAVM combined with tumor, 1 case of scalp arteriovenous fistula and 1 case of critical brain trauma in which a foreign metal stick approached the basal vascular circuit.Abnormalities were found in 16 cases in intraoperative angiography. The clinical data of all patients was collected as a perspective cohort. The success rate of hybrid surgery, intra-operative and post-operative complications, morbidity, mortality, rate of infection, the length of hospital stay were all analyzed to illustrate the effect of hybrid operation mode to traditional surgical pattern. Results: For 64 cases with intracranial aneurysms, the immediate complete occlusion rate was 90.5%, with a mortality of 4.7% and a morbidity of 14.0%. For 28 cases of BAVM and 12 cases of DAVF, all patients achieved total obliteration and favorable social independent outcomes after hybrid surgery, with no complication.For 6 cases of carotid artery stenosis and 5 cases of Moyamoya, intra-operative confirmed good cerebral reperfusion without any new post-operative neurologic deficits. After tumor vessels embolization, 4 out of 12 cases of hypervascular tumor needed intra-operative blood transfusion, and all patients achieved total tumor resection in a single stage. Only one patient with medulla oblongata hemangioblastoma died 6 months after operation due to respiratory deficit related pneumonia. Compared to traditional surgeries, the hybrid operation pattern did not significantly increase the total infection rate, central nervous system infection rate, hospital stay days and post-operative hospital stay days (all P>0.05) while the in-patient cost increased mildly (119 332 yuan vs.98 215 yuan, t=2.38, P=0.02). Conclusions: The operations of complex cerebral and spinal vascular diseases and intracranial hypervascular tumors can be performed in hybrid operation suite safely.This surgical mode can ensure the quality of operation and promote the development of innovative and complicated surgical procedures.


Subject(s)
Central Nervous System Neoplasms/surgery , Central Nervous System Vascular Malformations/surgery , Cerebrovascular Disorders/surgery , Spinal Cord Vascular Diseases/surgery , Vascular Surgical Procedures/methods , Adolescent , Adult , Aged , Central Nervous System/blood supply , Central Nervous System/surgery , Embolization, Therapeutic , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Vascular Diseases/surgery , Young Adult
12.
Acta Cytol ; 63(3): 224-232, 2019.
Article in English | MEDLINE | ID: mdl-30982032

ABSTRACT

OBJECTIVE: Intraoperative examination is a highly valuable tool for the evaluation of central nervous system (CNS) lesions, helping the neurosurgeon to determine the best surgical management. This study aimed to evaluate the accuracy and to analyze the diagnostic disagreements and pitfalls of the intraoperative examinations through correlation with the final histopathological diagnosis in CNS lesions. STUDY DESIGN: Retrospective analysis of intraoperative examination of CNS lesions and their final diagnosis obtained during 16 consecutive years. All diagnoses were reviewed and classified according to World Health Organization (WHO) grading for CNS tumors. Squash was performed in 119 cases, while frozen section and both methods were done in 7 cases each. RESULTS: Among the 133 intraoperative examinations considered, 114 (85.7%) presented concordance and 19 (14.3%) diagnostic disagreement when compared with subsequent histopathological examinations. The sensitivity and specificity for the detection of neoplasia in intraoperative examination was 98 and 94%, respectively. The positive and negative predictive values were 99 and 88%, respectively. The accuracy for neoplastic and nonneoplastic disease was 85.7%. Disagreements were more frequent among low-grade (WHO grades I and II) neoplasms and nonmalignant cases. CONCLUSIONS: Our results showed good accuracy of the intraoperative assessments for diagnosis of CNS lesions, particularly in high-grade (grades III and IV) lesions and metastatic neoplasms.


Subject(s)
Central Nervous System Diseases/diagnosis , Central Nervous System Neoplasms/diagnosis , Central Nervous System/pathology , Intraoperative Neurophysiological Monitoring/methods , Adolescent , Adult , Aged , Aged, 80 and over , Central Nervous System/physiopathology , Central Nervous System/surgery , Central Nervous System Diseases/physiopathology , Central Nervous System Diseases/surgery , Central Nervous System Neoplasms/physiopathology , Central Nervous System Neoplasms/surgery , Child , Child, Preschool , Cytodiagnosis/methods , Female , Humans , Infant , Male , Middle Aged , Retrospective Studies , Sensitivity and Specificity , Young Adult
13.
J Neurosurg Spine ; 30(1): 106-110, 2018 10 12.
Article in English | MEDLINE | ID: mdl-30485230

ABSTRACT

Superficial siderosis of the central nervous system (SSCNS) is an uncommon and often unrecognized disorder that results from recurrent and persistent bleeding into the subarachnoid space. Currently, there is no effective treatment for SSCNS. The identification and surgical resolution of the cause of bleeding remains the most reliable method of treatment, but the cause of bleeding is often not apparent. The identified sources of recurrent bleeding have typically included neoplasms, vascular malformations, brachial plexus or nerve root injury or avulsion, and previous head and spinal surgery. An association between recurrent bleeding in the CNS and dural abnormalities in the spine has recently been suggested. Dural tears have been identified in relation to a protruding disc or osteophyte. Also in these patients, the exact mechanism of bleeding remains unknown because of a lack of objective surgical data, even in patients who undergo neurosurgical procedures.The present case concerns a 48-year-old man who presented with longstanding symptoms of mild hearing loss and mild gait ataxia. A diagnosis of SSCNS was made in light of the patient's history and the findings on physical examination, imaging, and laboratory testing. MRI and CT detected a small calcific osteophyte in the anterior epidural space of T8-9. The patient underwent surgical removal of the bone spur and dural tear repair. During the surgery, the authors detected a perforating artery, which was on the osteophyte, that was bleeding into the subarachnoid space. This case shows a possible mechanism of chronic bleeding from an osteophyte into the subarachnoid space. In the literature currently available, a perforating artery on an osteophyte bleeding into the subarachnoid space has never been described in SSCNS.


Subject(s)
Osteophyte/surgery , Siderosis/surgery , Subarachnoid Hemorrhage/etiology , Subarachnoid Hemorrhage/surgery , Arteries/surgery , Central Nervous System/surgery , Hemosiderin/therapeutic use , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Neurosurgical Procedures/adverse effects , Osteophyte/complications , Osteophyte/diagnosis , Rupture , Siderosis/diagnosis , Subarachnoid Space/surgery
14.
Clin Neurol Neurosurg ; 168: 147-152, 2018 05.
Article in English | MEDLINE | ID: mdl-29550691

ABSTRACT

Hemangioblastomas (HBLs) are challenging vascular tumours with rare suprasellar location Surgery is recommended in patients with visual impairment, endocrine disorders or hydrocephalus. Surgical removal of pituitary stalk HBLs is challenging due to their location and high vascularity. Our narrative review was guided by the question: "what is the more suitable surgical approach to excise a suprasellar HBL?". Pertinent English literature was scrutinized from database inception to October 2016. Eighteen articles matched our selection criteria. Among the surgically treated patients, 4 were treated through a trans-sphenoidal (TS) approach, 13 through a transcranial approach (2 of them after TS failure). Five other cases were treated with radiotherapy (adjuvant in 3 cases) and 9 patients were managed with simple observation and/or medical treatment. We add a case of complete suprasellar HBL resection through an orbito-zygomatic (OZ) craniotomy with extradural anterior clinoidectomy (EAC). To achieve satisfactory oncologic results with acceptable morbidity for symptomatic suprasellar HBLs, complete tumour removal with pituitary stalk sparing should be attempted through an OZ craniotomy with EAC that provides adequate exposure of the tumour, its vascular supply and the adjacent neural structures.


Subject(s)
Central Nervous System/surgery , Hemangioblastoma/surgery , Pituitary Gland/surgery , Pituitary Neoplasms/surgery , Central Nervous System/pathology , Hemangioblastoma/diagnosis , Humans , Pituitary Neoplasms/diagnosis , Sella Turcica/pathology , Skull/surgery
15.
Neurocir.-Soc. Luso-Esp. Neurocir ; 28(5): 251-256, sept.-oct. 2017. ilus
Article in English | IBECS | ID: ibc-167473

ABSTRACT

Fluorescence-guided resection with 5-aminolevulinic acid has been shown to be useful in the resection of certain brain tumors other than high grade gliomas, facilitating the intraoperative differentiation of neoplastic tissue. The technique enables the surgeon to ensure that no tumor fragments remain, thereby achieving higher rates of complete resection. Tihan first described pilomyxoid astrocytomas in 1999. They are currently classified as grade II astrocytoma according to the WHO classification system and, because of their tendency to recur and their dissemination through the cerebrospinal fluid pathways, they are considered to be more aggressive than pilocytic astrocytoma. As a result, management of these tumors must be more aggressive, always aiming for complete macroscopic resection whenever possible. In this article, we present a case of pilomyxoid astrocytoma of the third ventricle in which the use of fluorescence-guided resection with 5-ALA facilitated complete resection. Imaging tests performed after five years revealed no signs of recurrence and no adjuvant radiotherapy or chemotherapy was required. This article also comprises a review of the literature concerning the characteristics and management of this tumor, which was recently considered to be a different histopathological entity


La resección guiada por fluorescencia con 5-ALA se ha mostrado útil en tumores diferentes a los gliomas de alto grado, permitiendo la diferenciación intraoperatoria del tejido tumoral. La técnica permite revisar el lecho quirúrgico para comprobar que no quedan fragmentos tumorales, consiguiéndose así mejorar las tasas de resección completa. El astrocitoma pilomixoide, descrito en 1999 por Tihan, se clasifica actualmente como un astrocitoma grado II en la clasificación de la OMS y es considerado como una variante con mayor agresividad que el astrocitoma pilocítico por su tendencia a la recidiva y a la diseminación por el líquido cefalorraquídeo. Por ello el tratamiento debe ser más agresivo, fundamentado en una resección macroscópicamente completa siempre que se pueda. En este artículo presentamos el caso de un astrocitoma pilomixoide del tercer ventrículo en el que la fluorescencia con 5-ALA permitió una resección completa, sin signos de recidiva en pruebas de imagen a los 5 años, sin haber precisado tratamiento complementario con radioterapia ni quimioterapia. Se hace además una revisión de la literatura acerca de las características y el manejo de este tumor recientemente considerado como una entidad histopatológica diferente


Subject(s)
Humans , Male , Young Adult , Astrocytoma/drug therapy , Astrocytoma/surgery , 5-Aminolevulinate Synthetase/radiation effects , Third Ventricle/diagnostic imaging , Third Ventricle/surgery , Neurosurgical Procedures/instrumentation , Fluorescence , Third Ventricle/pathology , Monitoring, Intraoperative/instrumentation , Central Nervous System/pathology , Central Nervous System/radiation effects , Central Nervous System/surgery
16.
Rev. neurol. (Ed. impr.) ; 64(7): 305-312, 1 abr., 2017. ilus, graf, tab
Article in Spanish | IBECS | ID: ibc-161602

ABSTRACT

Introducción. Las malformaciones cavernosas son lesiones vasculares del sistema nervioso central constituidas por endotelio sinusoidal que forma capilares agrupados o cavernas que carecen de los elementos típicos de una pared arterial madura y ausencia de tejido neural interpuesto. El endotelio está rodeado por una densa capa de fibras colágenas que dejan pequeñas hendiduras por las que se extravasa hemosiderina. Se comunican con el sistema vascular a muy baja presión y su tratamiento puede ser por microcirugía o radiocirugía. Objetivos. Analizar las malformaciones cavernosas supratentoriales tratadas quirúrgicamente en nuestra institución (FLENI), determinar la epidemiología y las características intrínsecas, estudiar la clínica de presentación, determinar las indicaciones quirúrgicas y complicaciones, y establecer el pronóstico. Pacientes y métodos. Estudio retrospectivo analítico de historias clínicas e imágenes de pacientes operados de malformaciones cavernosas supratentoriales en la FLENI desde enero de 1996 hasta diciembre de 2013. Resultados. Evaluamos a 51 pacientes, de 34 años de media, seguidos durante una media de 30 meses. El 1,96% de los pacientes presentó diagnóstico incidental y el resto mostró síntomas. El 23,52% presentó hemorragia en el momento del diagnóstico. En todas las cirugías se logró una exéresis total de las malformaciones cavernosas supratentoriales. Se observó un caso de meningitis postoperatoria. Conclusiones. La tasa de sangrado de las malformaciones cavernosas supratentoriales en nuestro medio es del 1,38% por paciente por año. El tratamiento quirúrgico es eficaz para erradicar o disminuir los síntomas y para evitar un posible resangrado. Presenta una tasa muy baja de complicaciones y un pronóstico neurológico favorable (AU)


Introduction. Cavernous malformations are vascular malformations of the central nervous system formed by a group of capillaries not covered by pia mater and communicated to the vascular system at very low pressure with very slow flow. Surgery or radiosurgery are the treatment modalities. Aims. To analyze our results after surgical treatment of supratentorial cavernous malformations, reviewing clinical presentation, surgical indications and postoperative complications. Patients and methods. Analytical retrospective study of medical records and images of patients who underwent resection of supratentorial cavernomas at FLENI from January 1996 until December 2013. Results. We evaluated 51 patients, mean age 34 years, followed for an average of 30 months. In 1.96% of patients diagnosis was incidental, the rest all presented symptoms. Bleeding at diagnosis was observed in 23.52%. Total excision of supratentorial cavernous malformations was possible in all cases. The only postoperative complication was one case of meningitis. Conclusions. The bleeding rate of supratentorial cavernous malformations in our series was 1.38% per patient per year. Surgical treatment effectively eliminated, or at least reduced symptoms, prevented rebleeding, and decreased need for antiepileptic drug therapy. Surgery have a low complication rate and good outcome (AU)


Subject(s)
Humans , Male , Female , Adult , Microsurgery/methods , Incidental Findings , Epilepsy/complications , Epilepsy/diagnosis , Cerebral Angiography , Cavernous Sinus/abnormalities , Cavernous Sinus/surgery , Cavernous Sinus , Central Nervous System/abnormalities , Central Nervous System/surgery , Prognosis , Retrospective Studies , Cerebrum/abnormalities , Cerebrum/surgery , Cerebrum , Neuroimaging
17.
No Shinkei Geka ; 45(3): 219-224, 2017 Mar.
Article in Japanese | MEDLINE | ID: mdl-28297687

ABSTRACT

Taste(gustation)is one of the five senses, and comprises the types: sweet, bitter, salty, sour, and umami. Taste disorders, such as dysgeusia and parageusia, are classified into 2 types: those with peripheral origin and those with central origin. The peripheral origin-type taste disorder is caused by zinc deficiency, mouth dryness, a side effect of radiotherapy or complication of systemic diseases such as, diabetes, hepatopathy, and nephropathy. The central origin-type taste disorder is reported to be caused due to demyelinating disease, pontine hemorrhage, pontine infarction, and thalamic infarction; it is very rarely caused by a brain tumor. We surgically treated a 69-year-old man with cerebellar hemangioblastoma who had developed taste disorder. The tumor compressed the solitary nucleus, which includes the taste tract in the central nervous system. On removal of the tumor, the taste disorder gradually improved.


Subject(s)
Cerebellar Neoplasms/surgery , Cerebral Infarction/surgery , Hemangioblastoma/surgery , Taste Disorders/surgery , Aged , Central Nervous System/pathology , Central Nervous System/surgery , Cerebellar Neoplasms/complications , Cerebellar Neoplasms/diagnosis , Cerebral Infarction/complications , Hemangioblastoma/complications , Hemangioblastoma/diagnosis , Humans , Male , Taste/physiology , Taste Disorders/complications , Taste Disorders/diagnosis , Treatment Outcome
18.
World Neurosurg ; 97: 58-63, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27693766

ABSTRACT

OBJECTIVE: This study aimed to summarize the clinical characteristics of Rosai-Dorfman disease primarily involving the central nervous system and to explore diagnosis and treatment. METHODS: We analyzed the clinical, imaging, and pathologic characteristics; treatment; and prognosis in 3 cases of Rosai-Dorfman disease primarily involving the central nervous system. We also performed a literature review. RESULTS: The largest of multiple intracranial lesions was totally resected, and steroid administration and radiotherapy were performed in phases for the remaining lesions. During the 1-year follow-up period, the excised lesion did not recur, and no obvious variations were observed in the other lesions. Subtotal resection was performed of the largest of another group of multiple intracranial lesions, and the residual did not show any obvious variations during the 1-year follow-up period. The isolated lesion was totally resected and did not recur during a 2-year follow-up period. CONCLUSIONS: Rosai-Dorfman disease with multiple lesions primarily involving the central nervous system is rare. Imaging characteristics are similar to meningiomas, and the pathological features include lymphocytes and plasma cells reaching tissue cells with large volume and abundant cytoplasm. Surgery is the preferred treatment, as the effects of steroid administration and radiotherapy are not apparent.


Subject(s)
Central Nervous System/diagnostic imaging , Histiocytosis, Sinus/pathology , Histiocytosis, Sinus/therapy , Neurosurgical Procedures/methods , Adult , Aged , Central Nervous System/drug effects , Central Nervous System/radiation effects , Central Nervous System/surgery , Female , Histiocytosis, Sinus/diagnostic imaging , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Male , Radiotherapy/methods , Steroids/therapeutic use , Tomography Scanners, X-Ray Computed
19.
Sci Rep ; 6: 35944, 2016 10 24.
Article in English | MEDLINE | ID: mdl-27775024

ABSTRACT

Neural interface technologies including recording and stimulation electrodes are currently in the early phase of clinical trials aiming to help patients with spinal cord injuries, degenerative disorders, strokes interrupting descending motor pathways, or limb amputations. Their lifetime is of key importance; however, it is limited by the foreign body response of the tissue causing the loss of neurons and a reactive astrogliosis around the implant surface. Improving the biocompatibility of implant surfaces, especially promoting neuronal attachment and regeneration is therefore essential. In our work, bioactive properties of implanted black polySi nanostructured surfaces (520-800 nm long nanopillars with a diameter of 150-200 nm) were investigated and compared to microstructured Si surfaces in eight-week-long in vivo experiments. Glial encapsulation and local neuronal cell loss were characterised using GFAP and NeuN immunostaining respectively, followed by systematic image analysis. Regarding the severity of gliosis, no significant difference was observed in the vicinity of the different implant surfaces, however, the number of surviving neurons close to the nanostructured surface was higher than that of the microstructured ones. Our results imply that the functionality of implanted microelectrodes covered by Si nanopillars may lead to improved long-term recordings.


Subject(s)
Central Nervous System/surgery , Foreign-Body Reaction/pathology , Nanostructures/adverse effects , Prostheses and Implants/adverse effects , Prosthesis Implantation/adverse effects , Silicon/adverse effects , Animals , Cell Death , Cell Proliferation , Gliosis/pathology , Neuroglia/physiology , Neurons/pathology , Optical Imaging , Rats, Wistar
20.
Br J Neurosurg ; 30(3): 280-5, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26853515

ABSTRACT

Cerebral aspergillosis, is an infrequent, opportunistic infection of the central nervous system that accounts for 5-10% of all intracranial fungal pathology. It is uncommon in immunocompetent patients and has a significant disease burden, with high morbidity and mortality, even with appropriate treatment. Basic principles of abscess management should be employed, including aspiration and targeted anti-fungal therapy for 12-18 months. However, reported outcomes with a purely minimally invasive approach are poor and there should be a low threshold for surgical excision, especially in resource poor settings and in patients with deteriorating neurology harbouring sizeable masses. Evidence favouring gross total excision over subtotal resection is lacking, however. It is notable that these recommendations are largely based on retrospective case series and isolated case reports. There is a need therefore for international collaboration to evaluate management strategies for immunocompetent patients with cerebral aspergillosis.


Subject(s)
Antifungal Agents/therapeutic use , Aspergillosis/drug therapy , Central Nervous System/surgery , Nervous System Diseases/drug therapy , Nervous System Diseases/surgery , Aspergillosis/immunology , Aspergillosis/surgery , Central Nervous System/pathology , Humans , Nervous System Diseases/immunology , Postoperative Care , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...